Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN was delisted on the 3rd of June, 2024.
37 hedge funds and large institutions have $320M invested in Fusion Pharmaceuticals Inc. Common Shares in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
28% more funds holding
Funds holding: 29 → 37 (+8)
5% more capital invested
Capital invested by funds: $304M → $320M (+$16M)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.91M |
| 2 |
BlackRock
New York
|
+$4.66M |
| 3 |
SCM
Sio Capital Management
New York
|
+$2.17M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$447K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$351K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$10.2M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.25M |
| 3 |
Millennium Management
New York
|
-$1.71M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$444K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$443K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
26
AlphaCentric Advisors
San Juan,
Puerto Rico
| $194K | +$160K | +12,700 | +334% |
|
27
Goldman Sachs
New York
| $166K | +$178K | +14,157 | New |
|
28
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| $155K | +$163K | +13,000 | New |
|
29
Bank of Montreal
Toronto,
Ontario, Canada
| $115K | +$56K | +4,462 | +82% |
|
30
Citigroup
New York
| $15K | +$15.8K | +1,254 | New |
|
|
PCM
31
Penserra Capital Management
Orinda,
California
| $11K | +$12K | +955 | New |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
S
33
SignatureFD
Atlanta,
Georgia
| $4K | – | – | – |
|
|
PHK
34
Point72 Hong Kong
Hong Kong
| $3K | +$3.02K | +240 | New |
|
35
Daiwa Securities Group
Tokyo,
Japan
| $1K | +$980 | +78 | New |
|
|
APA
36
American Portfolios Advisors
Holbrook,
New York
| $353 | – | – | – |
|
|
FCM
37
Farallon Capital Management
San Francisco,
California
| – | -$2.25M | -187,600 | Closed |
|
|
38
AllianceBernstein
Nashville,
Tennessee
| – | -$444K | -36,942 | Closed |
|
|
HF
39
HRT Financial
New York
| – | -$121K | -10,068 | Closed |
|
40
JP Morgan Chase
New York
| – | +$301 | +24 | New |
|
FUSN Hedge Fund Activity: Q4 2020 in Review
37 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q4 2020, worth a combined $320M — up 5.2% from $304M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FUSN positions and 3 closed out — a net gain of 8 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $6.91M. The largest seller was Deerfield Management, cutting an estimated $10.2M.
- 37 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q4 2020, up from 29 in Q3 2020.
- Funds reported $320M of Fusion Pharmaceuticals Inc. Common Shares stock for Q4 2020, up 5.2% quarter-over-quarter.
- 11 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q4 2020 and 3 closed out, a net change of +8 holders.
- The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q4 2020 was Point72 Asset Management, an estimated $6.91M added.
- The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q4 2020 was Deerfield Management, an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2020.